Review and Update of Device Establishment Inspection Processes and Standards

On 26 June 2020 the FDA announced the availability of the final guidance for industry.

FDA is issuing this guidance to comply with section 702(b)(2) of the FDA Reauthorization Act of 2017 (FDARA) (Public Law 115-52), which directs the FDA to issue guidance that specifies how the Agency will implement uniform processes and standards that are applicable to inspections (other than for-cause) of foreign and domestic device establishments. FDA updated processes and standards as needed to address the new provisions in section 704(h)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) that were added by FDARA section 702(a) and to establish a standard timeframe for inspections. This guidance also describes standardized methods of communication during the inspection process and identifies practices for investigators and device establishments to facilitate the continuity of inspections of such establishments.

Read more online 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /